US Reschedules CBD Drug

US Reschedules CBD Drug

Roughly three months after the Food and Drug Administration approved the cannabis-derived pharmaceutical Epidiolex for the treatment of epilepsy disorders, the US government has officially rescheduled drugs that contain CBD - but only if they've already been greenlighted by the FDA. 

https://bit.ly/2OmjSzh

Back to News